Evidence map›Paper›PMID 39087934›Full record

ArticleInvestigative ophthalmology & visual science2024

Functional Characterization of ABCA4 Missense Variants Aids Variant Interpretation and Phenotype Prediction in Patients With ABCA4-Retinal Dystrophies.

Sigrid Aslaksen, Ingvild Aukrust, Laurie Molday, Josephine Prener Holtan, Ragnhild Wivestad Jansson, Siren Berland, Eyvind Rødahl, Cecilie Bredrup, Ragnheiður Bragadóttir, Eirik Bratland and 2 more

Abstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Sigrid AslaksenDepartment of Clinical Science, University of Bergen, Bergen, Norway.
Ingvild AukrustDepartment of Clinical Science, University of Bergen, Bergen, Norway.
Laurie MoldayDepartment of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, BC, Canada.
Josephine Prener HoltanDepartment of Ophthalmology, Oslo University Hospital, Oslo, Norway.
Ragnhild Wivestad JanssonDepartment of Ophthalmology, Haukeland University Hospital, Bergen, Norway.
Siren BerlandDepartment of Medical Genetics, Haukeland University Hospital, Bergen, Norway.
Eyvind RødahlDepartment of Ophthalmology, Haukeland University Hospital, Bergen, Norway.
Cecilie BredrupDepartment of Ophthalmology, Haukeland University Hospital, Bergen, Norway.
Ragnheiður BragadóttirDepartment of Ophthalmology, Oslo University Hospital, Oslo, Norway.
Eirik BratlandDepartment of Clinical Science, University of Bergen, Bergen, Norway.
Robert S MoldayDepartment of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, BC, Canada.
Per Morten KnappskogDepartment of Clinical Science, University of Bergen, Bergen, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Biallelic pathogenic variants in the gene encoding the ATP-binding cassette transporter ABCA4 are the leading cause of irreversible vision loss in inherited retinal dystrophies (IRDs). Interpretation of ABCA4 variants is challenging, due to cis-modifying and hypomorphic variants. We have previously detected 10 missense variants of unknown significance (VUS) in patients with suspected ABCA4-retinal dystrophies (ABCA4-RDs) in Norway. In this study, we functionally characterized the VUS to aid interpretation of the variants and to determine if they are associated with the disease. Methods: The ABCA4 VUS were expressed in HEK293T cells and the ABCA4 expression level and ATPase activity were determined and correlated with the patients' phenotype. The functional data further used for reclassification of the VUS following the American College of Medical Genetics and Genomics (ACMG) guidelines. Results: Of the 10 VUSs, 2 variants, Cys205Phe and Asn415Thr, were categorized as functionally severe. The age at presentation in the 2 patients carrying these variants was divergent and seemed to be driven by the patients' second pathogenic variants Gly1961Glu and c.5461-10T>C, respectively. Three variants, Val643Gly, Pro799Leu, and Val1433Ile were categorized as functionally moderate, and were found in patients with intermediate/late age at presentation. The remaining five variants were categorized as functionally normal/mild. Based on our data, c.614G>T p.(Cys205Phe), c.1244A>C p.(Asn415Thr), and c.2396C>T p.(Pro799Leu) were reclassified to (likely) pathogenic, while 4 of the functionally normal/mild variants could be reclassified to likely benign. Conclusions: Functional analyses of ABCA4 variants are a helpful tool in variant classification and enable us to better predict the disease severity in patients with ABCA4-RDs.

Indexed as

ATP-Binding Cassette TransportersMutation, MissensePhenotypeRetinal DystrophiesAdultDNA Mutational AnalysisFemaleHEK293 CellsHumansMalePedigreeABCA4 protein, humanATP-Binding Cassette Transporters

Identifiers

PMID39087934
PMCPMC11305421

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.